Express Scripts Holding Company (NASDAQ:ESRX) Under Analyst Spotlight

Express Scripts Holding Company (NASDAQ:ESRX) Under Analyst Spotlight

Express Scripts Holding Company (NASDAQ:ESRX) Under Analyst Spotlight

The growth estimate for the next five years is 5.01 percent (per annum).

Total adjusted claims amounted to $354.9 million, down 6% year over year due to faster roll-off of the Coventry business. The average revenue estimate for the year ending December 2017 is $83.85B by 25 analysts. Expect increased sales in the current quarter as well.

Zacks offers analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. The High end of the Estimate is $4.11 Billion, while the Low end of the Estimate is $3.61 Billion. That value represents a market adjusting for revenues that have been falling by -5.01 % on a quarterly year/year basis as of the company's last quarterly report.

Express Scripts Holding Company (NASDAQ:ESRX) Price to Earnings (P/E) ratio is 16.46. At present, 1 analysts call it Sell, while 13 think it is Hold. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.

Express Scripts Holding Company (NASDAQ:ESRX) has a market capitalization of 42.07 Billion. Express Scripts Holding Company has a 52-week low of $64.46 and a 52-week high of $80.02.

The counter witnessed a trading volume of 6.93 million shares versus an average volume of 4.04 million shares during last trading session.

Meanwhile, Express Scripts Holding has repurchased a total of 74.4 million shares under the share repurchase program for $5,571.9 million during 2016.

Express Scripts Holding Company (NASDAQ:ESRX) is now showing its ROA (Return on Assets) of 5.3%. The company's Relative strength index is 62.76. Express Scripts Holding Company had a return on equity of 24.99% and a net margin of 2.70%. The score shows the rating on a scale of 1 to 5, where 1=strong buy and 5=strong sell.

Several investment firms issued their expert ratings on Express Scripts Holding Company (NASDAQ:ESRX) in which UBS Initiates Coverage on Express Scripts Holding Company (NASDAQ:ESRX) to Neutral with no specific Price Target on 10/06/16. The mean PT is calculated considering the consensus of 18 analysts.

Express Scripts Holding Company (NASDAQ:ESRX)went down -0.24% during trading on the United States exchange where it had a trading capacity of 6.93M shares. For trailing twelve months, EPS value for the stock is $4.22. Given the stock's recent action, it seemed like a good time to take a closer look at the company's recent data. The stock remained 2.00% volatile for the week and 2.09% for the month. The correct version of this report can be viewed at The company reported $1.74 EPS for the quarter, meeting analysts' consensus estimates of $1.74. 0 analysts recommended Overweight these shares while 1 recommended Underweight, according to FactSet data.

The earnings of Express Scripts Holding Company (ESRX) are forecasted by the analysts to move at $1.35 in current quarter, from $1.22 a year-ago quarter. Ten analysts surveyed by Zacks expected $26.27 billion. As per the consensus estimate, the company's year-on-year revenue growth is expected to be at 22.44% during the period.

Which way NetApp, Inc. (NASDAQ:NTAP) earning numbers may go
HAL unveils prototype of multi role helicopter at Aero India 2017